Xingquan Zhao
M.D., Chief Physician, Professor,
Doctorial Tutor of Capital Medical University，  
Executive Deputy Director and Party branch secretary of Center of Neurology, Beijing Tiantan Hospital, Capital Medical University, China.
EDUCATION:
Advanced study in management, Health management talent training class, Tsinghua University                                                      Sep.2004- Sep.2005
M.D. in Neurology, Capital Medical University                       Sep.2001- Jul. 2004
M.M. in Neurology, Capital Medical University                       Sep.1997- Jul. 1999
Bachelor of Medicine in Clinical Medicine, Shandong Medical College  Sep.1984- Jul. 1989
High school degree in No.1 middle school in Yuncheng, Heze City, Shandong Provinve    
                                                               Sep.1982- Jul. 1984
EMPOLYMENT:
Chief Physician; Executive Deputy Director and Party branch secretary of Center of Neurology, Beijing Tiantan Hospital, Capital Medical University                  Oct.2006 to present
Associate Chief Physician; Executive Deputy Director and Party branch secretary of Department of Neurology, Beijing Tiantan Hospital, Capital Medical University
                                                              Sep.2004- Sep.2006
Associate Chief Physician; Party branch secretary of Department of Neurology, Beijing Tiantan Hospital, Capital Medical University                      Dec.2000 –Aug. 2004.08
Attending Physician in Department of Neurology, Beijing Tiantan Hospital, Capital Medical University                                                    Oct.1994-Nov.2000
Resident in Department of Neurology, Beijing Tiantan Hospital, Capital Medical University    
                                                        Aug.1989-Sep.1994

Areas of Specificity：Cerebrovascular disease, Vertigo, Neurological intensive medicine, Epidemiology of cerebrovascular disease in community population, etc.

Scholarly Attainment:
Professor Zhao has focused on cerebrovascular disease and vertigo research, and made outstanding contributions in the fields of clinical, basic and translational medicine. He was the first to state clinical characteristics, present status of treatment and prognosis of hemorrhagic stroke in China comprehensively and systematically, which was funded by multiple projects, such as National Science and Technology Major Project of the Ministry of Science and Technology of China, National Key Technology Research and Development Program of the Ministry of Science and Technology of China and National Natural Science Foundation of China etc. Also, Prof. Zhao has firstly completed the research of predicting the outcome of cerebral hemorrhage patients using CTA, and has created the probable standard to predict hematoma expansion by performing one-step multimodal CT and the risk stratification system of cerebral hemorrhage. Meanwhile, Prof. Zhao has co-established a healthy population-based cohort (Kailuan study) including a total of 101,510 participants, and has promoted the primary prevention and intervention of stroke in community, as well as establishing hundreds stroke units and its digital management system in China. He is leading in providing group practice of vertigo and creating new technology, and also popularized and standardized the treatment of dizziness or vertigo by public-speaking tours. Prof. Zhao has lots of patents for utility model and provincial science and technology awards. He was chosen as Beijing Medical High Level Academic Backbone, Beijing Medical High Level Academic Leader and the “Dengfeng” talent of Beijing Municipal Administration of Hospitals’ Ascent Plan. He has published many papers in the SCI journals with total IF>150 points, and participated in compiling many textbooks, academic books or articles, national norms and guidelines for diagnosis and treatment, etc.

Membership in professional associations:
Deputy Secretary-General of Chinese Stroke Association;
Standing director of first council of Chinese Stroke Association;
Chairman of Management and Improvement of Chinese Medical Care Quality on Stroke;
Vice-chairmen of Vertigo Specialized Committee, Beijing Medical Association;
Vice-chairmen of Vertigo Specialized Committee, Chinese Research Hospital Association;
Member of the Standing Committee of Chinese society of Neurology, Chinese Medical Association;
Member of Cerebral vascular disease group, Beijing society of Neurology, Chinese Medical Association;
Member of Stroke prevention and control Specialized Committee, Chinese Preventive Medicine Association;
Member of medical expert database, Chinese Medical Association;
Member of Cerebrovascular disease Executive Committee, China National Clinical Research Center for Neurological Diseases;
Member of Rehabilitation Institute Committee of Chinese Hospital Association;
Vice President and Secretary General of Beijing Stroke Association;
Member of expert database of occupational disease diagnosis and identification in Beijing
Member of Chinese Society of Hypertension, China International Exchange and Promotive Association for Medical and Health Care;
Deputy editor-in-chief of Chinese Journal of Cerebrovascular Diseases(Electronic Edition).

Awards:
Beijing Medical High Level Academic Backbone                                2010
Beijing Medical High Level Academic Leader                                   2014
“Dengfeng” talent of Beijing Municipal Administration of Hospitals’ Ascent Plan      2015
Numerous awards: Beijing Science and Technology Award, Outstanding Party Worker, etc.
Such as:
1. Science and Technology Award of China Association of Chinese Medicine, National level / First prize in Jan.2012
2. Beijing Science and Technology Award, Provincial and ministerial level/ Third prize in Oct.2002
3. Beijing Science and Technology Award, Provincial and ministerial level/ Second prize(ranking as the second) in Jan.2014
4. Science and Technology Award of Chinese Preventive Medicine Association, National level / First prize(ranking as the third) in Oct.2013
5. Beijing Science and Technology Award, Provincial and ministerial level/ First prize(ranking as the second) in Oct.2014
6. Award for Science and Technology Progress, National level / First prize(ranking as the second) in Feb.2015
7. Science and Technology Award of Hebei Province, Provincial and ministerial level/ Second prize in Jan.2016

Representative SCI papers:
1. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack, JAMA. 2016 Jul 5;316(1):70-8. (IF=8.23)
2. The Association between Serum Uric Acid Levels and the Prevalence of Vulnerable Atherosclerotic Carotid Plaque: A Cross-sectional Study, Sci Rep. 2015 May 11;5:10003.(IF=5.578)
3. Effect of menopausal status on carotid intima-media thickness and presence of carotid plaque in Chinese women generation population, Sci Rep. 2015 Jan 28;5:8076. (IF=5.578)
4. Different blood pressure indexes on intracranial arterial stenosis in Asymptomatic Polyvascular Abnormalities in Community study in China, J Hypertens. 2015 Jul;33(7):1452-7.(IF=4.72)
5. Arterial pre-hypertension and hypertension in intracranial versus extracranial cerebrovascular stenosis, Eur J Neurol. 2015 Mar;22(3):533-9.(IF=4.055)